Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of Il8rb polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse,Rat |
| Host species | Rabbit |
| Applications | IP,IHC,WB-Re |
More info about Il8rb polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB8942 |
| Product name: | Il8rb polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of Il8rb. |
| Gene id: | 12765|29385 |
| Gene name: | Il8rb |
| Gene alias: | CD128|CDw128|CXCR2|Cmkar2|Gpcr16|IL-8Rh|IL-8rb|IL8RA|mIL-8RH |
| Gene description: | interleukin 8 receptor, beta |
| Immunogen: | A synthetic peptide corresponding to C-terminus of rat/mouse Il8rb. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:500) Immunoprecipitation (1:250) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In buffer containing 0.02% sodium azide |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Mouse,Rat |
| Reactivity: | Human,Mouse,Rat |
| Application image: |  |
| Application image note: | Western blot of Il8rb polyclonal antibody (Cat # PAB8942) with Chemokine receptor. Antibody dilution at 1:500. |
| Applications: | IP,IHC,WB-Re |
| Shipping condition: | Dry Ice |
| Publications: | The role of chemokines and chemokine receptors in progressive renal diseases.Segerer S. Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S15-8. |